Skip to main content

Program Modules

Module 1

Overview, Impact, Diagnosis, and Management of C3G

The goal of this module is to assess the current clinical landscape of C3G, including the prevalence, impact on healthcare systems, and associated economic burden, and describe the underlying pathogenesis, diagnostic approaches, and management of C3G.

Module 2

Emerging Treatments for C3G: A Focus on Complement Inhibitors

The goal of this module is to evaluate the most recent clinical findings concerning C3G treatment, including the limitations of conventional therapies and the potential of new and emerging complement inhibitors.

Module 3

Managed Care Considerations for C3G

The goal of this module is to implement cost-effective and evidence-based managed care policies to improve patient outcomes and minimize the burden of C3G.

Supported by

Supported by an educational grant from Apellis Pharmaceuticals.

Faculty

Abdallah S. Geara, MD

 Associate Professor of   Clinical Medicine      University of Pennsylvania      Philadelphia, Pennsylvania 

Russell Spjut, PharmD

  Director,                     Formulary Management        Prime Therapeutics             Salt Lake City, Utah

About Us Contact Us Terms/Privacy Policy

HMPloyee Login

HMP Global Products

Aggrego Consultant360 VRTX HMP Global Learning Network

© 2023 HMP Global. All Rights Reserved. Privacy Policy Terms of Use